Published in Psychiatr Clin North Am on September 01, 2009
Fragmentation and unpredictability of early-life experience in mental disorders. Am J Psychiatry (2012) 1.23
Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus. Psychoneuroendocrinology (2011) 1.09
The Age of Onset of Anxiety Disorders. Can J Psychiatry (2016) 1.06
Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biol Psychiatry (2011) 0.96
Toward Understanding How Early-Life Stress Reprograms Cognitive and Emotional Brain Networks. Neuropsychopharmacology (2015) 0.95
Interpersonal stress regulation and the development of anxiety disorders: an attachment-based developmental framework. Front Behav Neurosci (2011) 0.94
Music-based interventions in palliative cancer care: a review of quantitative studies and neurobiological literature. Support Care Cancer (2013) 0.91
Genetic approaches to understanding post-traumatic stress disorder. Int J Neuropsychopharmacol (2013) 0.90
Diagnostic Biomarkers for Posttraumatic Stress Disorder: Promising Horizons from Translational Neuroscience Research. Biol Psychiatry (2015) 0.88
Nicotine modulation of fear memories and anxiety: Implications for learning and anxiety disorders. Biochem Pharmacol (2015) 0.87
Naturalistic rodent models of chronic early-life stress. Dev Psychobiol (2014) 0.87
Revise the revised? New dimensions of the neuroanatomical hypothesis of panic disorder. J Neural Transm (Vienna) (2012) 0.86
The common traits of the ACC and PFC in anxiety disorders in the DSM-5: meta-analysis of voxel-based morphometry studies. PLoS One (2014) 0.86
Fetal growth and the lifetime risk of generalized anxiety disorder. Depress Anxiety (2010) 0.81
Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats. Behav Brain Funct (2013) 0.81
An allosteric modulator of metabotropic glutamate receptors (mGluR₂), (+)-TFMPIP, inhibits restraint stress-induced phasic glutamate release in rat prefrontal cortex. J Neurochem (2012) 0.81
Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value? Neurosci Biobehav Rev (2012) 0.81
Glucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibition. Eur J Neurosci (2014) 0.80
The role of the amygdala in the pathophysiology of panic disorder: evidence from neuroimaging studies. Biol Mood Anxiety Disord (2012) 0.80
High-affinity α4β2 nicotinic receptors mediate the impairing effects of acute nicotine on contextual fear extinction. Neurobiol Learn Mem (2015) 0.77
Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram. Psychopharmacology (Berl) (2014) 0.77
Meta-analysis of P300 waveform in panic disorder. Exp Brain Res (2014) 0.77
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nat Commun (2017) 0.75
Response to stress in Drosophila is mediated by gender, age and stress paradigm. Stress (2015) 0.75
Prenatal stressors in rodents: Effects on behavior. Neurobiol Stress (2016) 0.75
Reduced autobiographical memory specificity is associated with impaired discrimination learning in anxiety disorder patients. Front Psychol (2015) 0.75
Three-dimensional scoring of zebrafish behavior unveils biological phenomena hidden by two-dimensional analyses. Sci Rep (2017) 0.75
A positron emission tomography study of the serotonergic system in relation to anxiety in depression. Eur Neuropsychopharmacol (2017) 0.75
An integrative theory of prefrontal cortex function. Annu Rev Neurosci (2001) 36.82
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (1996) 16.04
Predictors of posttraumatic stress disorder and symptoms in adults: a meta-analysis. Psychol Bull (2003) 9.42
Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex (1993) 7.13
Allelic variation of human serotonin transporter gene expression. J Neurochem (1996) 7.08
The oxytocin receptor system: structure, function, and regulation. Physiol Rev (2001) 6.97
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Switching on and off fear by distinct neuronal circuits. Nature (2008) 5.22
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry (2001) 4.55
Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42
Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol (2001) 4.00
Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97
The cortical representation of pain. Pain (1999) 3.96
The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication. Arch Gen Psychiatry (2005) 3.96
Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91
When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry (2003) 3.68
Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry (2004) 3.54
Amygdala and ventrolateral prefrontal cortex activation to masked angry faces in children and adolescents with generalized anxiety disorder. Arch Gen Psychiatry (2008) 3.22
The neural correlates of anhedonia in major depressive disorder. Biol Psychiatry (2005) 3.16
FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem (2004) 2.91
Ventrolateral prefrontal cortex activation and attentional bias in response to angry faces in adolescents with generalized anxiety disorder. Am J Psychiatry (2006) 2.90
Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol Psychiatry (2005) 2.89
Genetic and environmental influences on trauma exposure and posttraumatic stress disorder symptoms: a twin study. Am J Psychiatry (2002) 2.82
The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry (2007) 2.81
The NPY system in stress, anxiety and depression. Neuropeptides (2004) 2.51
Social anxiety disorder. Lancet (2008) 2.49
Long-term behavioral and neuroendocrine adaptations to adverse early experience. Prog Brain Res (2000) 2.45
The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol Med (2005) 2.45
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci (2003) 2.37
Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35
Elevated CSF corticotropin-releasing factor concentrations in posttraumatic stress disorder. Am J Psychiatry (1997) 2.22
A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem (2001) 2.21
Neuroimaging studies of amygdala function in anxiety disorders. Ann N Y Acad Sci (2003) 2.21
Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology (2000) 2.08
Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry (2005) 2.06
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.93
Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry (2005) 1.91
Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. J Psychiatr Res (2005) 1.88
Biology of posttraumatic stress disorder. J Clin Psychiatry (2001) 1.88
The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry (2005) 1.79
Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol (2008) 1.76
Low urinary cortisol excretion in patients with posttraumatic stress disorder. J Nerv Ment Dis (1990) 1.63
A developmental twin study of symptoms of anxiety and depression: evidence for genetic innovation and attenuation. Psychol Med (2008) 1.59
Disorder-specific neuroanatomical correlates of attentional bias in obsessive-compulsive disorder, panic disorder, and hypochondriasis. Arch Gen Psychiatry (2005) 1.58
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease. Pharmacol Ther (2007) 1.57
The role of glutamate in anxiety and related disorders. CNS Spectr (2005) 1.53
Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol Psychiatry (1991) 1.52
Childhood trauma and risk for PTSD: relationship to intergenerational effects of trauma, parental PTSD, and cortisol excretion. Dev Psychopathol (2001) 1.50
Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med (2007) 1.46
Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety (2008) 1.45
Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav (2006) 1.43
Neurotransmitter regulation of cellular activation and neuropeptide gene expression in the paraventricular nucleus of the hypothalamus. J Neurosci (2002) 1.43
A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry (2007) 1.42
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry (1998) 1.42
Role of the amygdala in fear extinction measured with potentiated startle. Ann N Y Acad Sci (2003) 1.40
Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry (2005) 1.36
The neural networks of inhibitory control in posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.36
The role of GABA in the pathophysiology and treatment of anxiety disorders. Psychopharmacol Bull (2003) 1.36
Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring. J Psychiatr Res (2001) 1.33
fMRI predictors of treatment outcome in pediatric anxiety disorders. Psychopharmacology (Berl) (2006) 1.30
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry (2004) 1.26
Riluzole in the treatment of mood and anxiety disorders. CNS Drugs (2008) 1.24
Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci (2003) 1.22
Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav Brain Res (2006) 1.22
A high risk twin study of combat-related PTSD comorbidity. Twin Res (2003) 1.22
Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry (2004) 1.20
Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry (2000) 1.20
The participation of galanin in pain processing at the spinal level. Trends Pharmacol Sci (2002) 1.18
The neural correlates of social anxiety disorder and response to pharmacotherapy. Neuropsychopharmacology (2006) 1.16
HPA axis activity in patients with panic disorder: review and synthesis of four studies. Depress Anxiety (2007) 1.16
Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder. Neuroimmunomodulation (2001) 1.15
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry (2000) 1.15
Rostral anterior cingulate volume predicts treatment response to cognitive-behavioural therapy for posttraumatic stress disorder. J Psychiatry Neurosci (2008) 1.15
The ACTH response to dexamethasone in PTSD. Am J Psychiatry (2004) 1.12
Functional MRI changes during panic anticipation and imagery exposure. Neuroreport (2001) 1.12
Interactions between NPY and CRF in the amygdala to regulate emotionality. Neuropeptides (2004) 1.11
A population-based twin study of generalized anxiety disorder in men and women. J Nerv Ment Dis (2001) 1.11
Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry (2001) 1.11
fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. J Affect Disord (2006) 1.10
Neural systems for executive and emotional processing are modulated by symptoms of posttraumatic stress disorder in Iraq War veterans. Psychiatry Res (2008) 1.09
Open-label trial of riluzole in generalized anxiety disorder. Am J Psychiatry (2005) 1.07
Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group II metabotropic glutamate receptors. J Pharmacol Exp Ther (1998) 1.06
HPA axis response to a psychological stressor in generalised social phobia. Psychoneuroendocrinology (2002) 1.05
Impact of prosocial neuropeptides on human brain function. Prog Brain Res (2008) 1.05
Hypothalamus-pituitary-adrenal axis hyperresponsiveness is associated with increased social avoidance behavior in social phobia. Biol Psychiatry (2008) 1.04
Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol (2004) 1.04
Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus. Neuroendocrinology (1992) 1.03
HPA- and HPT-axis alterations in chronic posttraumatic stress disorder. Psychoneuroendocrinology (2006) 1.02
Superior temporal gyrus volumes in pediatric generalized anxiety disorder. Biol Psychiatry (2002) 1.02
Biology of post-traumatic stress disorder in childhood and adolescence. J Neuroendocrinol (2008) 1.02
Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology (Berl) (2004) 1.01
Combined effects of exonic polymorphisms in CRHR1 and AVPR1B genes in a case/control study for panic disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 1.01
The corticotropin-releasing hormone test in patients with posttraumatic stress disorder. Biol Psychiatry (1989) 1.01
Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord (2007) 1.00
Neurobiological mechanisms in generalized anxiety disorder. J Clin Psychiatry (2001) 1.00
Brain regions showing increased activation by threat-related words in panic disorder. Neuroreport (2003) 0.99
Molecular targets in the treatment of anxiety. Biol Psychiatry (2002) 0.99
Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA (2008) 6.60
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch Gen Psychiatry (2008) 4.65
Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci (2002) 4.52
The role of dopamine in the pathophysiology of depression. Arch Gen Psychiatry (2007) 4.51
The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry (2005) 4.45
The link between childhood trauma and depression: insights from HPA axis studies in humans. Psychoneuroendocrinology (2008) 4.35
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. Am J Psychiatry (2014) 4.25
Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry (2009) 3.88
Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry (2006) 3.33
Different mechanisms of fear extinction dependent on length of time since fear acquisition. Learn Mem (2006) 3.30
Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26
Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology (2002) 3.24
Childhood trauma associated with smaller hippocampal volume in women with major depression. Am J Psychiatry (2002) 3.05
Early life programming and neurodevelopmental disorders. Biol Psychiatry (2010) 2.93
Brain-derived neurotrophic factor and tyrosine kinase receptor B involvement in amygdala-dependent fear conditioning. J Neurosci (2004) 2.73
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun (2005) 2.52
Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology (2005) 2.35
Impaired fear inhibition is a biomarker of PTSD but not depression. Depress Anxiety (2010) 2.27
Reduced glucocorticoid receptors: consequence or cause of depression? Trends Endocrinol Metab (2006) 2.26
Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry (2010) 2.25
How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD. Am J Psychiatry (2010) 2.24
Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol (2010) 2.17
Pain symptomatology and pain medication use in civilian PTSD. Pain (2011) 2.16
Depression, desperation, and suicidal ideation in college students: results from the American Foundation for Suicide Prevention College Screening Project at Emory University. Depress Anxiety (2008) 2.16
Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv (2005) 2.13
Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry (2003) 2.13
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder. Trends Neurosci (2011) 2.12
Amygdala BDNF signaling is required for consolidation but not encoding of extinction. Nat Neurosci (2006) 2.10
Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry (2011) 2.09
Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment. Biol Psychiatry (2003) 2.05
Importance of studying the contributions of early adverse experience to neurobiological findings in depression. Neuropsychopharmacology (2004) 2.03
The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02
Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder. Biol Psychiatry (2012) 2.02
Fear extinction in traumatized civilians with posttraumatic stress disorder: relation to symptom severity. Biol Psychiatry (2010) 2.02
Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. Am J Psychiatry (2003) 1.90
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology (2005) 1.89
Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc Natl Acad Sci U S A (2013) 1.86
Differential immune system DNA methylation and cytokine regulation in post-traumatic stress disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 1.83
Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry (2005) 1.80
Long-term behavioural and molecular alterations associated with maternal separation in rats. Eur J Neurosci (2007) 1.79
Risk and resilience: genetic and environmental influences on development of the stress response. Depress Anxiety (2009) 1.79
Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci Transl Med (2013) 1.74
The relationship of depression and diabetes: pathophysiological and treatment implications. Psychoneuroendocrinology (2011) 1.74
Prelimbic cortical BDNF is required for memory of learned fear but not extinction or innate fear. Proc Natl Acad Sci U S A (2010) 1.72
Implications of memory modulation for post-traumatic stress and fear disorders. Nat Neurosci (2013) 1.72
Regulation of gephyrin and GABAA receptor binding within the amygdala after fear acquisition and extinction. J Neurosci (2005) 1.72
The role of early adverse experience and adulthood stress in the prediction of neuroendocrine stress reactivity in women: a multiple regression analysis. Depress Anxiety (2002) 1.72
The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry (2007) 1.71
Alterations in diurnal cortisol rhythm and acoustic startle response in nonhuman primates with adverse rearing. Biol Psychiatry (2005) 1.65
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry (2002) 1.65
Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology (2007) 1.63
Hypercortisolemia and depression. Psychosom Med (2005) 1.60
Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry (2014) 1.60
Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation. Biol Psychiatry (2004) 1.59
Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation. Neuropsychopharmacology (2006) 1.59
Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry (2005) 1.58
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases. J Clin Psychiatry (2007) 1.54
The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry (2012) 1.54
Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem (2004) 1.53
Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry (2007) 1.51
Neurobiology of posttraumatic stress disorder. CNS Spectr (2009) 1.48
Self-reported depressive symptom measures: sensitivity to detecting change in a randomized, controlled trial of chronically depressed, nonpsychotic outpatients. Neuropsychopharmacology (2005) 1.47
International Study to Predict Optimized Treatment for Depression (iSPOT-D), a randomized clinical trial: rationale and protocol. Trials (2011) 1.46
Training-induced changes in the expression of GABAA-associated genes in the amygdala after the acquisition and extinction of Pavlovian fear. Eur J Neurosci (2007) 1.43
Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet (2013) 1.43
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42
Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am J Med Genet B Neuropsychiatr Genet (2010) 1.42
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
Effect of Childhood Trauma on Adult Depression and Neuroendocrine Function: Sex-Specific Moderation by CRH Receptor 1 Gene. Front Behav Neurosci (2009) 1.41
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry (2007) 1.40
Beta-catenin is required for memory consolidation. Nat Neurosci (2008) 1.40
DSM-5 and RDoC: progress in psychiatry research? Nat Rev Neurosci (2013) 1.38
Atypical antipsychotic administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry (2007) 1.38
Neurobiology of early life stress: clinical studies. Semin Clin Neuropsychiatry (2002) 1.38
Early interventions for PTSD: a review. Depress Anxiety (2012) 1.37
Early intervention may prevent the development of posttraumatic stress disorder: a randomized pilot civilian study with modified prolonged exposure. Biol Psychiatry (2012) 1.37
PTSD and gene variants: new pathways and new thinking. Neuropharmacology (2011) 1.34
Methylation quantitative trait loci (meQTLs) are consistently detected across ancestry, developmental stage, and tissue type. BMC Genomics (2014) 1.34
Learning-dependent structural plasticity in the adult olfactory pathway. J Neurosci (2008) 1.34
Pain medication use among patients with posttraumatic stress disorder. Psychosomatics (2006) 1.32
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity. Biol Psychiatry (2004) 1.32
Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist (2005) 1.31
RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons and hippocampal-based learning and memory. Proc Natl Acad Sci U S A (2010) 1.31
Parental depression: animal models of an adverse life event. Am J Psychiatry (2002) 1.29
Treatment barriers for low-income, urban African Americans with undiagnosed posttraumatic stress disorder. J Trauma Stress (2008) 1.29
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders. Arch Gen Psychiatry (2002) 1.29
Emotion dysregulation and negative affect: association with psychiatric symptoms. J Clin Psychiatry (2011) 1.27
Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry (2004) 1.26
Depression, antidepressants, and neurogenesis: a critical reappraisal. Neuropsychopharmacology (2011) 1.25
The neurobiological toll of child abuse and neglect. Trauma Violence Abuse (2009) 1.25
Accounting for population stratification in DNA methylation studies. Genet Epidemiol (2014) 1.25
An interactive web-based method of outreach to college students at risk for suicide. J Am Coll Health (2008) 1.23
Emotional learning and glutamate: translational perspectives. CNS Spectr (2005) 1.23